MagnetisMM-30

A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Refractory Multiple Myeloma

  • Myeloma Service

Sorting 14 by

Memorial Sloan Kettering Westchester
West Harrison, NY
  • Accepting patients
Memorial Sloan Kettering Nassau
Uniondale, NY
  • Accepting patients
Winship Cancer Institute
Emory University
Atlanta, GA
  • Not yet accepting
Simon Cancer Center
Indiana University
Indianapolis, IN
  • Accepting patients
150 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.